New York State Common Retirement Fund’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-52,300
Closed -$9.4M 3129
2017
Q3
$9.4M Sell
52,300
-5,518
-10% -$769K 0.01% 978
2017
Q2
$5.99M Buy
57,818
+11,913
+26% +$972K 0.01% 1190
2017
Q1
$3.6M Buy
45,905
+1,956
+4% +$121K ﹤0.01% 1383
2016
Q4
$1.97M Sell
43,949
-3,444
-7% -$169K ﹤0.01% 1707
2016
Q3
$2.65M Buy
47,393
+9,776
+26% +$545K ﹤0.01% 1522
2016
Q2
$1.88M Buy
37,617
+1,190
+3% +$58.5K ﹤0.01% 1641
2016
Q1
$1.67M Buy
36,427
+5,178
+17% +$251K ﹤0.01% 1694
2015
Q4
$1.93M Sell
31,249
-18,359
-37% -$1.29M ﹤0.01% 1617
2015
Q3
$2.76M Sell
49,608
-14,878
-23% -$936K ﹤0.01% 1456
2015
Q2
$3.93M Sell
64,486
-6,416
-9% -$366K 0.01% 1480
2015
Q1
$4.09M Buy
+70,902
New +$4.75M 0.01% 1315

New York State Common Retirement Fund's KITE Position: Q4 2017 in Review

New York State Common Retirement Fund sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 52,300 shares — an estimated $9.4M sold.

New York State Common Retirement Fund first reported a position in KITE in Q1 2015 and held it in 11 quarters. The position peaked at $9.4M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • New York State Common Retirement Fund reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • New York State Common Retirement Fund sold 52,300 Kite Pharma, Inc. shares in Q4 2017, an estimated $9.4M.
  • New York State Common Retirement Fund first reported a position in Kite Pharma, Inc. in Q1 2015 and held it in 11 quarters.
  • New York State Common Retirement Fund's Kite Pharma, Inc. position peaked at $9.4M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on New York State Common Retirement Fund's 13F filing for Q4 2017, filed 13 Feb 2018.